News
Stockhead on MSN19h
Health Check: With the FDA’s approval, EBR is ready to revolutionise the heart failure device marketThe US Food & Drug Administration (FDA) has approved EBR Systems' (ASX:EBR) WISE wireless pacemaker device, thus opening a ...
The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...
Researchers from Rutgers Health and RWJBarnabas Health have developed an artificial intelligence (AI) technology that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback